Cargando…
Angiopoietin-1: an early biomarker of diabetic nephropathy?
Autores principales: | Butler, Alexandra E., Al-Qaissi, Ahmed, Sathyapalan, Thozhukat, Atkin, Stephen L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513175/ https://www.ncbi.nlm.nih.gov/pubmed/34645474 http://dx.doi.org/10.1186/s12967-021-03105-9 |
Ejemplares similares
-
Glucose excursions in type 2 diabetes modulate amyloid-related proteins associated with dementia
por: Moin, Abu Saleh Md, et al.
Publicado: (2021) -
Letter to the Editor: Do biomarkers of COVID-19 severity simply reflect a stress response in type 2 diabetes: Biomarker response to hypoglycemia()()
por: Moin, Abu Saleh Md, et al.
Publicado: (2021) -
Mapping of type 2 diabetes proteins to COVID-19 biomarkers: A proteomic analysis
por: Moin, Abu Saleh Md, et al.
Publicado: (2020) -
Type 2 Diabetes Coagulopathy Proteins May Conflict With Biomarkers Reflective of COVID-19 Severity
por: Moin, Abu Saleh Md, et al.
Publicado: (2021) -
Potential Biomarkers to Predict Acute Ischemic Stroke in Type 2 Diabetes
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)